Cardiometabolic health can only be improved if providers can deliver care to the patients who need it. Practice management strategies include scheduling, billing, electronic health records, telehealth, care coordination, and other tools exist to help clinicians deliver best care to the patients who need it.
News Digest
Remembering Dr. Stephen HarrisonÂ
Cardiometabolic Health Congress Becomes First Organization to Offer Certification in Cardiometabolic Health
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
Cardiometabolic Health Congress Hosts 2023 Women’s Masterclass in California
The Utility of Genetic Testing in Cardiometabolic Health with Dr. Elizabeth McNally
Building Equity into the Equation: Stopping NAFLD & NASH in Black Americans
Where Our Worlds Collide: The Systemic Storm of Inflammation, Cardiovascular Disease and PsoriasisÂ
Personalizing Cardiometabolic Drug Therapies for Racial and Ethnic Minorities
Day 1 Recap: Great Debates
Effects of In-Utero COVID-19 Exposure on Infant Growth
Compared with their nonpregnant counterparts, pregnant women with COVID-19 experience a more severe disease course with increased rates of intensive care unit admission and need
Sleep Awareness Week 2023
Sleep Awareness Week® is observed from March 12-18, 2023. This year, the National Sleep Foundation (NSF) is celebrating the 25th anniversary of this annual call
Faculty Spotlight: Rachel M. Bond, MD
In recognition of Black History and Women’s History Months in February and March 2023, Cardiometabolic Health Congress (CMHC) hosted a one-hour virtual experience to address
Flu Vaccine Reduces Stroke Risk
Recent findings from a University of Calgary study show that individuals who recently received an influenza vaccination had a 22.5% lower risk of stroke compared
Expert Highlights and Perspectives
A cache of recorded faculty presentations addressing the diagnosis, clinical management, treatment, and emerging strategies related to a clinical array of cardiometabolic health-related conditions.
The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19
Listen to CMHC’s Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEis and ARBs should be withdrawn in patients with COVID-19.
Resources
A clinical array of resources for both patients and provider education and connection.